ACSRX | VIVIX | ACSRX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 26 years | - |
Gain YTD | 13.743 | 16.286 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12B | 183B | 7% |
Annual Yield % from dividends | 1.28 | 2.37 | 54% |
Returns for 1 year | 14.32 | 24.01 | 60% |
Returns for 3 years | 10.60 | 28.27 | 38% |
Returns for 5 years | 32.21 | 55.47 | 58% |
Returns for 10 years | 35.34 | 114.02 | 31% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TSLQ | 22.40 | 1.02 | +4.77% |
Tradr 2X Short TSLA Daily ETF | |||
BSCV | 16.76 | 0.01 | +0.06% |
Invesco BulletShares 2031 Corp Bd ETF | |||
ZECP | 30.70 | -0.01 | -0.03% |
Zacks Earnings Consistent ETF | |||
FGM | 38.56 | -0.56 | -1.43% |
First Trust Germany AlphaDEX® ETF | |||
NVDL | 53.50 | -1.81 | -3.27% |
GraniteShares 2x Long NVDA Daily ETF |